[Human spongiform encephalopathies in the Netherlands]

Area of Science:

• Neurology
• Epidemiology
• Public Health

Background:

• Creutzfeldt Jakob disease (CJD) is a rare, fatal neurodegenerative disorder.
• Centralized registration of CJD cases in the Netherlands commenced in 1997.
• Approximately 35 CJD cases are reported annually in the Netherlands.

Purpose of the Study:

• To describe the ongoing central registration of Creutzfeldt Jakob disease (CJD) cases in the Netherlands.
• To highlight the importance of continued surveillance for CJD, including transfusion-transmitted variants.

Main Methods:

• Centralized registration of all patients with possible, probable, or definite CJD diagnoses.
• Inclusion of registered cases in a European database.
• Monitoring for emerging CJD forms, such as transfusion-transmitted CJD.

Main Results:

• Since 1997, approximately 35 CJD cases have been reported annually in the Netherlands.
• All diagnosed CJD patients are registered in a European database.
• Transfusion-transmitted CJD cases have been identified in the UK but not yet in the Netherlands.

Conclusions:

• Continued central detection and registration of CJD patients in the Netherlands is essential.
• Surveillance efforts are vital for identifying and managing rare neurological diseases.
• The absence of transfusion-transmitted CJD in the Netherlands warrants ongoing vigilance.